Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Sleep Quality in Breast Cancer Surgery
NCT06773143Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Incidence of Postoperative Sleep Disturbance at 1 day. Started Dec 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT06773143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06773143.